PRILIGY 30 mg, film-coated tablet 3 tablets
Active ingredients: Dapoxetine hydrochloride, Dapoxetine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet3 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PRILIGY 30 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium avec sécurité enfant de 3 comprimé(s)
- Marketing authorisation holder
- PHOENIX LABS (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 21 Mar 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67084087CIP72226926CIP133400922269269Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DAPOXÉTINEcomprimé | 30 mg · un comprimé | FT |
| CHLORHYDRATE DE DAPOXÉTINEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.